ISR Phase I CRO Benchmarking Report 2024

Read more

Recently, Clinical Leader announced the 2024 Leadership Awards, supported by data from ISR Reports, recognizing Phase I CROs for comprehensive excellence across their capabilities, compatibility, expertise, quality, and reliability. 2024 marks the 11th consecutive year that Worldwide has been rated as a high-performing CRO based on primary market research, outperforming all other Phase I CROs for Overall User Preference. Download the report today.

Want to learn more about Worldwide Clinical Trials?